PUBLIC ADVOCATE DEFENDS PREVIOUS TRUMP BLOOD POLICY TO BAR ADDING HOMOSEXUALS AND OTHER RISKY BLOOD DONORS
OPEN LETTER TO PRESIDENT DONALD TRUMP
Dear President Trump,
I know you are working hard and only briefly responded to a reporter at a recent news conference with an expression of confidence in the staff at the FDA.
We know this does not preclude you taking another look at this betrayal of a previous Administration position and action to counter this risk to the American public.
We recgognize you have worked swiftly and very early to fight the China Corona Virus and keep the heat on bureaucrats at the FDA and the CDC and the entire government to speed up real solutions and not impede the fight against The China virus.
These government agencies spend a lot of money researching and pushing their agenda while ignoring hundreds of solutions in the private sector that would assist the actual collective health of the nation.
You have shown the ability to remove regulations and red tape to add these tools to fighting the current pandemic and saved millions of lives by your leadership worldwide.
In the question from the reporter: did you approve the lifting of restraints on practicing
Homosexuals to donate their blood into the blood supply, we know you did not approve this.
You previously overruled the same FDA. Public Advocate supported your previous ruling for many reasons.
The FDA Has a Long History of Ignoring Scientific Evidence In An Effort to appease the Homosexual Community.
The FDA's Prior Decision to Move to a One-Year Deferral Period Was Not Based on Science, But On a Continuing Desire to Pander to Homosexual Interest Groups.
The FDA Based Its Move to a One-Year Deferral Period in Part on Irrelevant Studies from Other Countries.
Now Contemplating Removing All Deferral Periods for MSM, the FDA Puts Its Faith Entirely in the Availability and Reliability of Post-Donation Blood Screening.
The FDA's Draft Guidance Operates in an "Alice in Wonderland" Type World of Dress-Up and Make-Believe.
A full amplification and detail is contained in our previous ten page testimony to the FDA comment period from 2016.
For all of these reasons, the FDA should be overuled and instead should decline the homosexual lobby's invitation to eliminate all deferral periods for blood donation. Moreover, the FDA should return to its indefinite deferral system that was in place before the ill-advised change in policy in December
Public Advocate of the US Inc.